Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare ...

Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff ...

Takeda (TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim ... Takeda’s president, chief executive officer (CEO) and ...

The Bold and the Beautiful Feb 14 Episode Recap: Finn Wrestles With His Thoughts; Ivy and Electra Reach Career Milestone Guri Dhairya Ki Love Story on OTT: Where to watch upcoming Aspirants spin ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

When Takeda CEO Christophe Weber retires from the company in June 2026, a familiar face among the Massachusetts biotech scene will take over leading the Japanese pharma giant. When Takeda CEO ...

Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.

Takeda Pharmaceutical 45020.65%increase; green up pointing triangle raised its annual earnings forecasts despite posting lower quarterly net profit, and it said Julie Kim, who heads its U.S ...

Takeda Pharmaceutical raised its annual earnings forecasts despite posting lower quarterly net profit, and it said Julie Kim, who heads its U.S. business unit, will become chief executive in 2026.

Takeda Pharmaceutical named Julie Kim, who heads its U.S. business ... president of its U.S. business unit, will succeed CEO Christophe Weber, who plans to step down in June next year.

Julie Kim Representative Director, President & Chief Executive Officer* President, U.S. Business Unit and U.S. Country Head Christophe Weber Retirement Representative Director, President & Chief ...